Stéphane Culine
- Cancer Research top 2%
- Cancer Genomics and Diagnostics 16
-
- Prostate Cancer Treatment and Research 44
- Renal cell carcinoma treatment 23
- Prostate Cancer Diagnosis and Treatment 17
- Oncology top 2%
- Cancer Immunotherapy and Biomarkers 20
- Cancer Treatment and Pharmacology 16
- Surgery top 2%
- Bladder and Urothelial Cancer Treatments 49
- Urinary and Genital Oncology Studies 26
- Molecular Biology top 5%
- Co-authors
- Christine ThéodoreJoaquim BellmuntHans von der MaaseYacine SalhiFrédéric RollandEric WinquistJean‐Pierre DrozF. Iborra
- Journals
- Journal of Clinical Oncology (29 papers)Annals of Oncology (18 papers)European Journal of Cancer (8 papers)
- Partner nations
- FranceUnited StatesSpain
In The Last Decade
Stéphane Culine
154 papers receiving 4.5k citations
Hit Papers
Peers
Comparison fields: 5 of 107
- Cancer Research 1.0k
- Pulmonary and Respiratory Medicine 2.0k
- Oncology 1.6k
- Surgery 1.7k
- Molecular Biology 1.4k
Countries citing papers authored by Stéphane Culine
This map shows the geographic impact of Stéphane Culine's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stéphane Culine with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stéphane Culine more than expected).
Fields of papers citing papers by Stéphane Culine
This network shows the impact of papers produced by Stéphane Culine. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stéphane Culine. The network helps show where Stéphane Culine may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Stéphane Culine, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2023 | 6 | |
| 3 | 2023 | 0 | |
| 4 | 2020 | 11 | |
| 5 | 2020 | 1 | |
| 6 | 2020 | 2 | |
| 7 | 2019 | 53 | |
| 8 | 2018 | 26 | |
| 9 | 2018 | 6 | |
| 10 | 2015 | 121 | |
| 11 | 2013 | 115 | |
| 12 | 2010 | 121 | |
| 13 | 2010 | 231 | |
| 14 | 2009 | 41 | |
| 15 | 2009 | 13 | |
| 16 | 2008 | 36 | |
| 17 | Pharmacokinetics of a nucleoside analogue CP-4055 in two phase I trials using a daily for 5 days schedule and three intermittent weekly or biweekly schedules | 2005 | 2 |
| 18 | [Radiotherapy and inhibitors of epidermal growth factor receptor: preclinical findings and preliminary clinical trials]. | 2003 | 7 |
| 19 | 1992 | 5 | |
| 20 | The human homologue of the putative proto-oncogene Spi-1: characterization and expression in tumors. | 1990 | 57 |
About Stéphane Culine
Stéphane Culine is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research, having authored 163 papers that have together received 4.6k indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (49 papers), Prostate Cancer Treatment and Research (44 papers), Urinary and Genital Oncology Studies (26 papers), Renal cell carcinoma treatment (23 papers), Cancer Immunotherapy and Biomarkers (20 papers), Prostate Cancer Diagnosis and Treatment (17 papers), Cancer Genomics and Diagnostics (16 papers) and Cancer Treatment and Pharmacology (16 papers). The work is most often cited by research in Cancer Research (1.0k citations), Pulmonary and Respiratory Medicine (2.0k citations) and Oncology (1.6k citations). Stéphane Culine has collaborated with scholars based in France, United States and Spain. Frequent co-authors include Christine Théodore, Joaquim Bellmunt, Hans von der Maase, Yacine Salhi, Frédéric Rolland, Eric Winquist, Jean‐Pierre Droz, F. Iborra, Stéphane Oudard and Toni K. Choueiri. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, European Journal of Cancer, European Urology and Anti-Cancer Drugs.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.